Fluorescent Diorganotin(IV) Complexes as Anticancer Agents: Study of Cytotoxicity, Cellular Localization, and Mechanism of Cell Death
暂无分享,去创建一个
[1] H. Görls,et al. Ruthenium(II)-dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria-targeted Apoptotic Cell Death. , 2023, Chemistry.
[2] T. Sasamori,et al. Mitochondria-Targeted Luminescent Organotin(IV) Complexes: Synthesis, Photophysical Characterization, and Live Cell Imaging. , 2022, Inorganic chemistry.
[3] Sharifah Nadhira Syed Annuar,et al. Triphenyltin(IV) dithiocarbamate compounds induce genotoxicity and cytotoxicity in K562 human erythroleukemia cells primarily via mitochondria-mediated apoptosis. , 2022, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[4] W. Kaminsky,et al. Methoxido‐Bridged Lacunary Heterocubane Oxidovanadium(IV) Cluster with Azo Ligands: Synthesis, X‐ray Structure, Magnetic Properties, and Antiproliferative Activity , 2022, European Journal of Inorganic Chemistry.
[5] H. Görls,et al. Evaluation of DNA/BSA interaction and in vitro cell cytotoxicity of μ2-oxido bridged divanadium(V) complexes containing ONO donor ligands. , 2022, Journal of inorganic biochemistry.
[6] T. Sasamori,et al. New mixed ligand oxidovanadium(IV) complexes: Solution behavior, protein interaction and cytotoxicity. , 2022, Journal of inorganic biochemistry.
[7] W. Kaminsky,et al. Dithiocarbazate based oxidomethoxidovanadium(V) and mixed-ligand oxidovanadium(IV) complexes: Study of solution behavior, DNA binding, and anticancer activity. , 2022, Journal of inorganic biochemistry.
[8] D. Sanna,et al. Mo(VI) Potential Metallodrugs: Explaining the Transport and Cytotoxicity by Chemical Transformations. , 2022, Inorganic chemistry.
[9] Jingmin Wang,et al. Highly hydrophilic quaternary ammonium salt containing organotin (IV) carboxylate for visualization of antibacterial action and multi-photon absorption activity , 2022, Dyes and Pigments.
[10] Xiaohe Tian,et al. A multi-photon fluorescence “on-off-on” probe based on organotin (IV) complex for high-sensitive detection of Cu2+ , 2022, Sensors and Actuators B: Chemical.
[11] E. Tiekink,et al. Water-Soluble Dioxidovanadium(V) Complexes of Aroylhydrazones: DNA/BSA Interactions, Hydrophobicity, and Cell-Selective Anticancer Potential. , 2021, Inorganic chemistry.
[12] E. Schott,et al. Organotin Schiff bases as halofluorochromic dyes: green synthesis, chemio-photophysical characterization, DFT, and their fluorescent bioimaging in vitro. , 2021, Journal of materials chemistry. B.
[13] M. Mohanty,et al. Protein binding and cytotoxic activities of monomeric and dimeric oxido-vanadium(V) salan complexes: Exploring the solution behavior of monoalkoxido-bound oxido-vanadium(V) complex. , 2021, Journal of inorganic biochemistry.
[14] Zhanhua Wang,et al. A Ru-anthraquinone dyad with triple functions of PACT, photoredox catalysis and PDT upon red light irradiation. , 2021, Dalton transactions.
[15] Xiaohe Tian,et al. Multi-photon absorption organotin complex for bioimaging and promoting ROS generation. , 2021, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[16] Pedro M. P. Gois,et al. Unveiling the Potential of Transition Metal Complexes for Medicine: Translational in Situ Activation of Metal‐Based Drugs from Bench to in Vivo Applications , 2021, Chembiochem : a European journal of chemical biology.
[17] K. Raghavachari,et al. In‐vitro and In‐vivo Photocatalytic Cancer Therapy with Biocompatible Iridium(III) Photocatalysts , 2021 .
[18] R. Karvembu,et al. Synthesis of Palladium(II) Complexes via Michael Addition: Antiproliferative Effects through ROS-Mediated Mitochondrial Apoptosis and Docking with SARS-CoV-2 , 2020, Inorganic chemistry.
[19] W. Kaminsky,et al. Probing CO Generation through Metal-Assisted Alcohol Dehydrogenation in Metal-2-(arylazo)phenol Complexes Using Isotopic Labeling (Metal = Ru, Ir): Synthesis, Characterization, and Cytotoxicity Studies. , 2020, Inorganic chemistry.
[20] A. Nieto-Camacho,et al. Organotin (IV) complexes from Schiff bases ligands based on 2-amino-3-hydroxypyridine: synthesis, characterization, and cytotoxicity , 2020, Medicinal Chemistry Research.
[21] W. Kaminsky,et al. New VIV, VIVO, VVO, and VVO2 Systems: Exploring their Interconversion in Solution, Protein Interactions, and Cytotoxicity. , 2020, Inorganic chemistry.
[22] M. Ghadermazi,et al. Synthesis, X-ray crystal structure, thermal behavior and evaluation as an in vitro cytotoxic agent of a tin(IV) complex containing dipicolinic acid , 2020 .
[23] T. Sasamori,et al. Synthesis, structure and characterization of new dithiocarbazate-based mixed ligand oxidovanadium(iv) complexes: DNA/HSA interaction, cytotoxic activity and DFT studies , 2020, New Journal of Chemistry.
[24] Manoj Kumar,et al. Organotin Complexes with Promising Therapeutic Potential , 2020, Current Pharmacology Reports.
[25] B. Campanella,et al. Exploring the Anticancer Potential of Diiron Bis-cyclopentadienyl Complexes with Bridging Hydrocarbyl Ligands: Behavior in Aqueous Media and In Vitro Cytotoxicity , 2020, Organometallics.
[26] G. Schenk,et al. Polynuclear zinc(II) complexes of thiosemicarbazone: Synthesis, X-ray structure and biological evaluation. , 2020, Journal of inorganic biochemistry.
[27] R. Baker,et al. Structure-activity relationships of new Organotin(IV) anticancer agents and their cytotoxicity profile on HL-60, MCF-7 and HeLa human cancer cell lines. , 2019, European journal of medicinal chemistry.
[28] Zhishan Xu,et al. Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes. , 2019, European journal of medicinal chemistry.
[29] V. Brabec,et al. Molecular superoxide radical photogeneration in cancer cells by dipyridophenazine iridium(iii) complexes , 2019, Inorganic Chemistry Frontiers.
[30] M. Řezáčová,et al. A Ruthenium(II) Complex Containing a Redox-Active Semiquinonate Ligand as Potential Chemotherapeutic Agent: From Synthesis to In Vivo Studies. , 2019, Journal of medicinal chemistry.
[31] L. Fournel,et al. Interconnection between Metabolism and Cell Cycle in Cancer. , 2019, Trends in biochemical sciences.
[32] S. Mobin,et al. Mitochondrial Localization of Highly Fluorescent and Photostable BODIPY-Based Ruthenium(II), Rhodium(III), and Iridium(III) Metal Complexes. , 2019, Inorganic chemistry.
[33] K. Sadler,et al. Potent and selective in vitro and in vivo antiproliferative effects of metal–organic trefoil knots† †Electronic supplementary information (ESI) available. CCDC 1549049. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c9sc01218d , 2019, Chemical science.
[34] Chengcheng Zhu,et al. Restraining Cancer Cells by Dual Metabolic Inhibition with a Mitochondrion-Targeted Platinum(II) Complex. , 2019, Angewandte Chemie.
[35] Xiaohe Tian,et al. A series of two-photon absorption organotin (IV) cyano carboxylate derivatives for targeting nuclear and visualization of anticancer activities. , 2019, Journal of inorganic biochemistry.
[36] Xiaohe Tian,et al. Organotin(IV) carboxylate complexes containing polyether oxygen chains with two-photon absorption in the near infrared region and their anticancer activity , 2018, Dyes and Pigments.
[37] Juanjuan Li,et al. Half-Sandwich Iridium and Ruthenium Complexes: Effective Tracking in Cells and Anticancer Studies. , 2018, Inorganic chemistry.
[38] E. Tiekink,et al. Synthesis, structure, solution behavior, reactivity and biological evaluation of oxidovanadium(iv/v) thiosemicarbazone complexes. , 2018, Dalton transactions.
[39] Xiaohe Tian,et al. Two-Photon-Active Organotin(IV) Complexes for Antibacterial Function and Superresolution Bacteria Imaging. , 2018, Inorganic chemistry.
[40] P. Dyson,et al. α-Diimines as Versatile, Derivatizable Ligands in Ruthenium(II) p-Cymene Anticancer Complexes. , 2018, Inorganic chemistry.
[41] Bing Tang,et al. Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules. , 2018, European journal of medicinal chemistry.
[42] A. Chávez-Reyes,et al. Organotin Dyes Bearing Anionic Boron Clusters as Cell-Staining Fluorescent Probes. , 2018, Chemistry.
[43] L. Ji,et al. Mitochondrial dynamics tracking with iridium(III) complexes. , 2018, Current opinion in chemical biology.
[44] Abhrajyoti Ghosh,et al. Schiff base supported mononuclear organotin(IV) complexes: Syntheses, structures and fluorescence cell imaging , 2018 .
[45] W. Tan,et al. Cell imaging of dopamine receptor using agonist labeling iridium(iii) complex , 2017, Chemical science.
[46] K. Acharya,et al. Syntheses, crystal structures, DFT calculations, protein interaction and anticancer activities of water soluble dipicolinic acid-imidazole based oxidovanadium(iv) complexes. , 2017, Dalton transactions.
[47] Juanjuan Li,et al. Half-sandwich ruthenium(ii) complexes containing N^N-chelated imino-pyridyl ligands that are selectively toxic to cancer cells. , 2017, Chemical communications.
[48] P. Sadler,et al. Organoiridium Photosensitizers Induce Specific Oxidative Attack on Proteins within Cancer Cells , 2017, Angewandte Chemie.
[49] W. Kaminsky,et al. Monomeric and Dimeric Oxidomolybdenum(V and VI) Complexes, Cytotoxicity, and DNA Interaction Studies: Molybdenum Assisted C═N Bond Cleavage of Salophen Ligands. , 2017, Inorganic chemistry.
[50] Weiying Lin,et al. A novel fluorescent probe with a large Stokes shift for real-time imaging mitochondria in different living cell lines , 2017 .
[51] Prashant K. Sharma,et al. Design, synthesis and theoretical analysis of functionalized dicarboxylate moieties based on organotin(IV) dinuclear complexes: crystal structure elucidation and biological studies , 2017 .
[52] I. Banerjee,et al. Synthesis, structure and cytotoxicity of a series of Dioxidomolybdenum(VI) complexes featuring Salan ligands. , 2017, Journal of inorganic biochemistry.
[53] A. Chávez-Reyes,et al. Luminescent Silk Fibroin with Organotin Compounds from Amino Acid Schiff Bases – Microwave‐Assisted Synthesis, Chemo‐Optical Characterization, Cytotoxicity, and Confocal Microscopy , 2017 .
[54] Xiaohe Tian,et al. Two-Photon Active Organotin(IV) Carboxylate Complexes for Visualization of Anticancer Action. , 2017, ACS biomaterials science & engineering.
[55] A. Crochet,et al. A study of DNA/BSA interaction and catalytic potential of oxidovanadium(v) complexes with ONO donor ligands. , 2016, Dalton transactions.
[56] Kangqiang Qiu,et al. Biscylometalated iridium(iii) complexes target mitochondria or lysosomes by regulating the lipophilicity of the main ligands. , 2016, Dalton transactions.
[57] R. Ramesh,et al. Ruthenium(II) arene complexes containing benzhydrazone ligands: synthesis, structure and antiproliferative activity , 2016 .
[58] J. Dou,et al. Cu(II), Ni(II) complexes derived from chiral Schiff-base ligands: Synthesis, characterization, cytotoxicity, protein and DNA-binding properties. , 2016, Journal of photochemistry and photobiology. B, Biology.
[59] Meiju Niu,et al. Anti-proliferative activity and DNA/BSA interactions of five mono- or di-organotin(IV) compounds derived from 2-hydroxy-N′-[(2-hydroxy-3-methoxyphenyl)methylidene]-benzohydrazone , 2016 .
[60] M. Salam,et al. Synthesis, structural characterization, and evaluation of biological activity of organotin(IV) complexes with 2-hydroxy-5-methoxybenzaldehyde-N(4)-methylthiosemicarbazone , 2016 .
[61] J. Xia,et al. Axial PEGylation of Tin Octabutoxy Naphthalocyanine Extends Blood Circulation for Photoacoustic Vascular Imaging. , 2016, Bioconjugate chemistry.
[62] Chun-lin Ma,et al. Syntheses, structures and anti-tumor activity of four new organotin(iv) carboxylates based on 2-thienylselenoacetic acid. , 2016, Dalton transactions.
[63] R. Sharma,et al. Synthesis, characterization and antimicrobial activity of diorganotin(IV) derivatives of some bioactive bifunctional tridentate Schiff base ligands , 2016 .
[64] E. Garribba,et al. Chemistry of Monomeric and Dinuclear Non-Oxido Vanadium(IV) and Oxidovanadium(V) Aroylazine Complexes: Exploring Solution Behavior. , 2016, Inorganic chemistry.
[65] A. Chávez-Reyes,et al. New application of fluorescent organotin compounds derived from Schiff bases: synthesis, X-ray structures, photophysical properties, cytotoxicity and fluorescent bioimaging. , 2015, Journal of materials chemistry. B.
[66] A. Crochet,et al. Synthesis, X-ray structure and in vitro cytotoxicity studies of Cu(I/II) complexes of thiosemicarbazone: special emphasis on their interactions with DNA. , 2015, Dalton transactions.
[67] W. Kaminsky,et al. Evaluation of the cell cytotoxicity and DNA/BSA binding and cleavage activity of some dioxidovanadium(V) complexes containing aroylhydrazones. , 2015, Journal of inorganic biochemistry.
[68] S. Etaiw,et al. A new organometallic complex based on the trimethyltin cation and 2,6-pyridinedicarboxylic acid as a potential anticancer agent , 2015 .
[69] Fei Wang,et al. Organotin(IV) complexes derived from Schiff base N'-[(1E)-(2-hydroxy-3-methoxyphenyl)methylidene]pyridine-4-carbohydrazone: synthesis, in vitro cytotoxicities and DNA/BSA interaction. , 2014, European journal of medicinal chemistry.
[70] R. Santillán,et al. Synthesis and photophysical characterization of organotin compounds derived from Schiff bases for organic light emitting diodes , 2014 .
[71] N. Jana,et al. Facile tuning of the aggregation-induced emission wavelength in a common framework of a cyclometalated iridium(III) complex: micellar encapsulated probe in cellular imaging , 2014 .
[72] E. Tiekink,et al. Syntheses and structural investigation of some alkali metal ion-mediated LV(V)O2(-) (L(2-) = tridentate ONO ligands) species: DNA binding, photo-induced DNA cleavage and cytotoxic activities. , 2014, Dalton transactions.
[73] D. Pérez-Quintanilla,et al. Organotin(IV)-loaded mesoporous silica as a biocompatible strategy in cancer treatment. , 2014, Angewandte Chemie.
[74] V. Revankar,et al. Synthesis, crystal structures and characterization of late first row transition metal complexes derived from benzothiazole core: anti-tuberculosis activity and special emphasis on DNA binding and cleavage property. , 2014, European journal of medicinal chemistry.
[75] N. Zhang,et al. Main group bismuth(III), gallium(III) and diorganotin(IV) complexes derived from bis(2-acetylpyrazine)thiocarbonohydrazone: synthesis, crystal structures and biological evaluation. , 2014, Dalton transactions.
[76] E. Tiekink,et al. Highly stable hexacoordinated nonoxidovanadium(IV) complexes of sterically constrained ligands: syntheses, structure, and study of antiproliferative and insulin mimetic activity. , 2013, Inorganic chemistry.
[77] M. Greenberg,et al. The activity-dependent transcription factor NPAS4 regulates domain-specific inhibition , 2013, Nature.
[78] Qingshan Li,et al. Comparative toxicity and apoptosis induced by diorganotins in rat pheochromocytoma (PC12) cells. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[79] J. Padrón,et al. Novel clioquinol and its analogous platinum complexes: importance, role of the halogen substitution and the hydroxyl group of the ligand. , 2013, Dalton transactions.
[80] Prashant K. Sharma,et al. Synthesis, structural characterization, DNA binding studies and antitumor properties of tin(II)-oxydiacetate complexes containing α-diimine as auxiliary ligand. , 2013, Journal of photochemistry and photobiology. B, Biology.
[81] Tao Xu,et al. DNA binding, DNA cleavage and BSA interaction of a mixed-ligand copper(II) complex with taurine Schiff base and 1,10-phenanthroline. , 2013, Journal of photochemistry and photobiology. B, Biology.
[82] N. Desai,et al. Synthesis, antimicrobial and cytotoxic activities of some novel thiazole clubbed 1,3,4-oxadiazoles , 2013, European Journal of Medicinal Chemistry.
[83] G. Natile,et al. An Updated View of Cisplatin Transport , 2013 .
[84] D. S. Pandey,et al. DNA binding and anti-cancer activity of redox-active heteroleptic piano-stool Ru(II), Rh(III), and Ir(III) complexes containing 4-(2-methoxypyridyl)phenyldipyrromethene. , 2013, Inorganic chemistry.
[85] Rui Ge,et al. Apoptosis induced neurotoxicity of Di-n-butyl-di-(4-chlorobenzohydroxamato) Tin (IV) via mitochondria-mediated pathway in PC12 cells. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.
[86] L. Spiccia,et al. Molecular and cellular characterization of the biological effects of ruthenium(II) complexes incorporating 2-pyridyl-2-pyrimidine-4-carboxylic acid. , 2012, Journal of the American Chemical Society.
[87] T. Bakas,et al. Synthesis, structural characterization and in vitro inhibitory studies against human breast cancer of the bis-(2,6-di-tert-butylphenol)tin(IV) dichloride and its complexes. , 2012, Dalton transactions.
[88] N. Dharmaraj,et al. Organometallic ruthenium(II) complexes: synthesis, structure and influence of substitution at azomethine carbon towards DNA/BSA binding, radical scavenging and cytotoxicity. , 2012, European journal of medicinal chemistry.
[89] M. Yousefi,et al. New mononuclear diorganotin(IV) dithiocarboxylates: synthesis, characterization and study of their cytotoxic activities , 2012 .
[90] S. Gómez‐Ruiz,et al. Study of the Anticancer Properties of Tin(IV) Carboxylate Complexes on a Panel of Human Tumor Cell Lines , 2012, ChemMedChem.
[91] Louise N. Dawe,et al. Lanthanide complexes of tritopic bis(hydrazone) ligands: single-molecule magnet behavior in a linear Dy(III)3 complex. , 2012, Inorganic chemistry.
[92] P. Hergenrother,et al. Parallel synthesis and biological evaluation of 837 analogues of procaspase-activating compound 1 (PAC-1). , 2012, ACS combinatorial science.
[93] Chang Su Lim,et al. Ratiometric detection of mitochondrial thiols with a two-photon fluorescent probe. , 2011, Journal of the American Chemical Society.
[94] F. Arjmand,et al. Synthesis of new chiral heterocyclic Schiff base modulated Cu(II)/Zn(II) complexes: their comparative binding studies with CT-DNA, mononucleotides and cleavage activity. , 2011, Journal of photochemistry and photobiology. B, Biology.
[95] R. Peralta,et al. Electronic structure and spectro-structural correlations of Fe(III)Zn(II) biomimetics for purple acid phosphatases: relevance to DNA cleavage and cytotoxic activity. , 2010, Inorganic chemistry.
[96] G. Gasser,et al. Organometallic Anticancer Compounds , 2010, Journal of medicinal chemistry.
[97] Yuxiang Chen,et al. 2-, 3-, and 4-(1-Oxo-1H-2,3-dihydroisoindol-2-yl)benzoic acids and their corresponding organotin carboxylates: synthesis, characterization, fluorescent, and biological activities. , 2010, Bioorganic & medicinal chemistry letters.
[98] R. Mortara,et al. Therapeutic evaluation of free and liposome-loaded furazolidone in experimental visceral leishmaniasis. , 2010, International journal of antimicrobial agents.
[99] L. Galluzzi,et al. Targeting mitochondria for cancer therapy , 2010, Nature Reviews Drug Discovery.
[100] P. Sadler,et al. Cytotoxicity, hydrophobicity, uptake, and distribution of osmium(II) anticancer complexes in ovarian cancer cells. , 2010, Journal of medicinal chemistry.
[101] J. Reedijk. Platinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug Design , 2009 .
[102] M. Cilli,et al. In vitro cytotoxic activity of tri-n-butyltin(IV)lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumor activity in vivo , 2009, Investigational New Drugs.
[103] Paul J Hergenrother,et al. DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action. , 2007, Current opinion in biotechnology.
[104] V. S. Periasamy,et al. Mixed-ligand copper(II)-phenolate complexes: effect of coligand on enhanced DNA and protein binding, DNA cleavage, and anticancer activity. , 2007, Inorganic chemistry.
[105] Y. Urano,et al. Design and synthesis of fluorescent probes for selective detection of highly reactive oxygen species in mitochondria of living cells. , 2007, Journal of the American Chemical Society.
[106] P. Hergenrother,et al. Small-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategy , 2006, Nature chemical biology.
[107] M. Tong,et al. Double-strand DNA cleavage by copper complexes of 2,2'-dipyridyl with electropositive pendants. , 2006, Dalton transactions.
[108] C. Pettinari,et al. Chemical and Biotechnological Developments in Organotin Cancer Chemotherapy , 2006 .
[109] J. Ellena,et al. The synthesis and characterisation of Sn(IV) complexes of 2,6-pyridine dicarboxylate--the molecular structure of divinyltin(IV) derivative. , 2005, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.
[110] K. Ulbrich,et al. Polymeric anticancer drugs with pH-controlled activation. , 2004, Advanced drug delivery reviews.
[111] L. Pellerito,et al. Preparation and structural studies on dibutyltin(IV) complexes with pyridine mono- and dicarboxylic acids , 2004 .
[112] M. K. Chourasia,et al. Polysaccharides for Colon Targeted Drug Delivery , 2004, Drug delivery.
[113] J. Collins,et al. Multi-nuclear platinum complexes as anti-cancer drugs , 2003 .
[114] J. Chattopadhyaya,et al. Synthesis of [Ru(phen)(2)dppz](2+)-tethered oligo-DNA and studies on the metallointercalation mode into the DNA duplex. , 2001, Journal of the American Chemical Society.
[115] W. Wong,et al. Synthesis, Characterisation and Electrochemical Behaviour of Rhodium(III) Complexes Containing 1,2‐Naphthoquinone‐2‐oxime and Formation of Imine Complexes through N−O Bond Cleavage , 2001 .
[116] T. Kiss,et al. Aqueous Chemistry of Ammonium (Dipicolinato)oxovanadate(V): The First Organic Vanadium(V) Insulin-Mimetic Compound , 2000 .
[117] D. Crans,et al. Chemistry and insulin-like properties of vanadium(IV) and vanadium(V) compounds. , 2000, Journal of inorganic biochemistry.
[118] H. Fujita,et al. Apoptosis Induced by Nicotinamide-related Compounds and Quinolinic Acid in HL-60 Cells , 2000, Bioscience, biotechnology, and biochemistry.
[119] S. Macura,et al. Binding of 15N-labeled isoniazid to KatG and KatG(S315T): Use of two- spin [zz]-order relaxation rate for 15N-fe distance determination , 1999 .
[120] P. Sadler,et al. Metals in Medicine. , 1999, Angewandte Chemie.
[121] D. E. Fenton,et al. Metal Complexes of Bibracchial Schiff Base Macrocycles , 1996 .
[122] A. K. Mesmaeker,et al. New Charge Transfer Luminescent Polymetallic Complexes of Rhodium(III), Iridium(III), and Ruthenium(II) with the Bridging Ligand 1,4,5,8,9,12-Hexaazatriphenylene , 1995 .
[123] R. Watts,et al. Synthesis and characterizations of cyclometalated iridium(III) solvento complexes , 1994 .
[124] R. Peter,et al. Oral hydralazine therapy for primary pulmonary hypertension. , 1980, The New England journal of medicine.
[125] Saqib Ali,et al. Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations. , 2018, European journal of medicinal chemistry.
[126] N. Shams,et al. Study on the interaction between doxorubicin and Deoxyribonucleic acid with the use of methylene blue as a probe , 2009 .
[127] L. Pellerito,et al. Organotin(IV)n+ complexes formed with biologically active ligands: equilibrium and structural studies, and some biological aspects , 2002 .
[128] K. Ulbrich,et al. Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier. , 1995, European journal of cancer.